NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has signed a non-exclusive agreement with Synbio Technologies, a biotech company that focuses on DNA technology and applications.

The companies will work in tandem to provide customers worldwide with access to genes up to 70 kilobases in length.

"By leveraging our collective expertise in next-generation gene synthesis, we believe we will see new uses of DNA to improve the diagnosis and treatment of diseases," Synbio CEO Ping Yang said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.